Approval · Notice of Compliance 14700 · 2013
PRASCEND: Notice of Compliance 14700
Issued September 5, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14700
- Date
- September 5, 2013
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Dopaminergic agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRASCEND | 02412217 | Marketed |
Medicinal ingredients
- PERGOLIDE MESYLATE 1 MG per TAB